RYTM EPS Estimates
Rhythm Pharmaceuticals, Inc.
$86.17
-$1.80(-2.05%)
42
Overall
40
Value
9
Tech
78
Quality
Market Cap
$5.93B
Volume
367.04K
52W Range
$74.50 - $122.20
Target Price
$140.00
RYTM EPS estimates: the consensus estimate for Rhythm Pharmaceuticals, Inc.'s current fiscal year is -$2.86 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RYTM EPS Estimates
- EPS estimate, current quarter
- $-0.68
- EPS estimate, next quarter
- $-0.64
- EPS estimate, current year
- $-2.86
- EPS estimate, next year
- $-0.43
- EPS growth, 3-year
- +3.59%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.11 |
| 2024 | $-4.34 |
| 2023 | $-3.20 |
| 2022 | $-3.47 |
| 2021 | $-1.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RYTM | $86.17 | -2.0% | 367.04K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rhythm Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW